J14
J14 is a reversible sulfiredoxin inhibitor with an IC50 of 8.1 μM. J14 induces oxidative stress (intracellular ROS accumulation) by inhibiting sulfiredoxin, leading to cytotoxicity and cancer cell death[1].
Product Specifications
CAS Number
1043854-13-2
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Neuroscience-Neurodegeneration
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/j14.html
Purity
99.91
Solubility
DMSO : ≥ 125 mg/mL
Smiles
O=C(O)C1=CC=C(CSC2=NC(C3=CC=CC=C3)=CC(N4CCN(C5=CC=CC=C5Cl)CC4)=N2)C=C1
Molecular Formula
C28H25ClN4O2S
Molecular Weight
517.04
Precautions
H302, H315, H319, H335
References & Citations
[1]Kim H, et al. Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage. Free Radic Biol Med. 2016 Feb;91:264-74.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![PCCA Mouse Monoclonal Antibody [Clone ID: OTI1B10]](https://cdn.genprice.uk/products/937/68dd18bb061270361e9089de/imageurl/cf810969.webp)
LY403003 100 µg
C6orf211 (ARMT1) (NM_024573) Human Over-expression Lysate
Sign In for Pricing
View Details 
